An interesting study separately evaluated the serum concentrations of the most bioactive apelin peptide fragments, namely, apelin-13 and apelin-36, in preeclampsia patients with the aim of exploring their potential association with perinatal morbidity. The gene discussed is APLN; the disease is preeclampsia.